Fully integrated AI decision support tool flags B scans that may require further review, supporting more confident decision making and more efficient patient care. ZEISS Medical Technology today announced CE mark approval for CIRRUS® PathFinder™, an innovative clinical support tool with artificial intelligence (AI) fully integrated to enable more confident decision-making and accelerate a clinician's […]
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, all dates inclusive (the “Class Period”), have until this Monday, August 25, 2025 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit.
Dabogratinib is the only oral FGFR3-selective inhibitor in clinical development for achondroplasia- Initial results from safety sentinel cohort expected in 2H 2026- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that the first child has
Mount Sinai South Nassau is expanding anesthesia services as its role as a teaching hospital grows. The expansion is being supported by Greater New York Anesthesia Services, P.C. (GNYAS), which will provide full anesthesia services for the Oceanside-based hospital. Mount Sinai South Nassau is a 455-bed hospital located in Oceanside, New York that currently runs
Daniel P. O'Toole, managing partner of the premier New York law firm Block O'Toole & Murphy, has been named the New York City 2026 “Lawyer of the Year” in Personal Injury Litigation – Plaintiff by Best Lawyers®. This incredible honor is only awarded to one attorney per year in each practice area and geographic region.
— Bevacizumab Injection officially approved by Indonesia's National Agency of Drug and Food Control (BPOM), following Nigeria, Pakistan, and Colombia – accelerating global commercialization — Approval in ASEAN's largest pharma market strengthens BioDlink's position as a global supplier of antibody/XDC therapies via international GMP standards and commercial capabilities https://mma.prnewswire.com/media/2682341/BioDlink_EN_Logo.jpg SUZHOU, China, Aug. 21, 2025 /PRNewswire/–BioDlink
— Company holds a dedicated meeting with Gates Foundation executives during Bill Gates' visit to Korea. — Both reviews expanded cooperation, including next-generation preventive medicines. SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that the company held an exclusive meeting with the Gates
— Received the highest grade for the entire R&D process, from design to quality verification — Plans to mass-produce 20 million units of 16 major semiconductors developed in-house this year, and has established an R&D environment at the global top level — Takes the lead in expanding the domestic automotive semiconductor partnership ecosystem Hyundai Mobis
KoreanPropTech startup RSQUARE's RA (Rsquare Analytics) solution is reshaping how global investors view the Korean commercial real estate market. Until recently the market forced multi-million-dollar investment decisions to be made with limited transparency. Investors had to contact dozens of brokers or rely on personal networks to obtain even basic data such as prime office rent
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Amplo Biotechnology, a pioneer in adeno-associated virus (AAV) regenerative medicines for neuromuscular junction (NMJ) affecting conditions. The partnership will provide scalable manufacturing of clinical-grade AAV material, leveraging Andelyn's suspension AAV Curator® platform. https://mma.prnewswire.com/media/2420707/Andelyn_Biosciences_Logo.jpg Diseases of